UConn Health

Timothy Folta, professor of management, leads a class at the Graduate Business Learning Center in Hartford. (Peter Morenus/UConn File Photo)

Industry-Academic Program to Grow Entrepreneurial Know-How

The new program will provide aspiring entrepreneurs working as academic or industry researchers with customized training to help turn their technologies into businesses and products.

A human fetus in utero. (Getty Images)

Calm the Immune System, Halt Premature Birth

UConn Health researchers found that a drug that blocks the cytokine GM-CSF may reduce the number of preterm births.

Riley Blumenfield, a materials science and engineering student, discovered her passion for research thanks to Research Connections, an annual networking event for students and faculty. (Carson Stifel/UConn Photo)

Making Research Connections at UConn

Riley Blumenfield, a materials science and engineering student, Honors Program STEM scholar, and president of engineering sorority Phi Sigma Rho came to UConn knowing she wanted to be involved with research, but she didn’t know where to start. After attending an annual event to expose undergrads to a host of opportunities, she not only found […]

The DNA receptor (green) is bound to DNA (blue) inside immune cells (macrophages) (cell membrane colored pink) during infection. (Image courtesy of the Rathinam Lab)

Cell Death Protein also Damps Inflammation

A new study by UConn Health researchers shows how the body keeps inflammation in check, making double use of a protein previously thought to be responsible only for cell death.

Dividing fibrosarcoma cells. Colored scanning electron micrograph of fibrosarcoma (fibroblastic sarcoma) cells in the late telophase stage of mitosis. The cells are covered in many filopodia. Fibrosarcoma is a malignant tumour derived from fibrous connective tissue of the bone and characterized by immature proliferating fibroblasts or undifferentiated anaplastic spindle cells. (Getty Images)

Stopping the Resistance of Cancer Cells to Treatment

UConn researchers have discovered molecules that could make cancer cells more vulnerable to chemotherapy.

Researchers at UConn Health have shown how a mutated gene causes excess bone resorption in a rare bone disease known as Lehman Syndrome. (Jungeun Yu/UConn Photo)

When More Bone-making Cells Equal Less Bone

Researchers at UConn Health have shown how a mutated gene causes excess bone resorption in a rare bone disease known as Lehman Syndrome.

Men working at a chemical plant carrying barrels with toxic products. (Getty Images)

Labor Day Report: Occupational Illnesses Remain High in Connecticut

The report shows that the rate of occupational illness in Connecticut is 6 percent higher than the national average.

Cancer cells tend to hoard iron, and researchers at UConn Health have found that iron may be playing a critical role in fueling the cells' growth through increased fatty acid synthesis. (Yesenia Carrero/UConn Illustration)

Ovarian Cancer Cells Hoard Iron to Fuel Growth

Researchers at UConn Health have found that iron may be playing a critical role in increased fatty acid synthesis in cancer.

Dewayne Johnson, who used Roundup in his job as groundskeeper and later developed non-Hodgkin lymphoma, has been awarded $289 million in damages. (AP Photo via The Conversation)

Jury finds Monsanto Liable in the first Roundup Cancer Trial – Here’s What Could Happen Next

A UConn Health professor with experience of trying to help figure out why people get cancer discusses implications of the Roundup verdict.

A black father kisses the forehead of his newborn son. (Ariel Skelley/Getty Images)

Bridging the Health Care Gap

'Boys and men of color in our nation are uniquely underserved across a number of health indicators,' says Wizdom Powell, director of the Health Disparities Institute at UConn Health.